---
title: "PICCOS TRIAL"
ocid: "ocds-kuma6s-131480"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-kuma6s-131480"
markdown_url: "https://d3tenders.com/contract/ocds-kuma6s-131480.md"
json_url: "https://d3tenders.com/contract/ocds-kuma6s-131480.json"
source: "Sell2Wales"
current_stage: "Award"
buyer: "NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)"
published: "2023-05-11"
---

# PICCOS TRIAL

Buyer: NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)  
Current stage: Award  
OCID: ocds-kuma6s-131480

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-kuma6s-131480)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-kuma6s-131480.json)

## Summary

The NHS Wales Shared Services Partnership-Procurement Services, located in Cardiff, UK, initiated a tender process for the procurement of services related to the successful completion of the "PICCOS TRIAL". This trial, awarded without prior competition, aims to explore new chemotherapy delivery methods for patients with peritoneal metastases. The Cardiff University has been selected as the supplier due to its expertise in this research area. The procurement process was completed on May 11, 2023, and the contract value is £1,974,920.41.

This procurement opportunity within the healthcare industry presents business growth potential for service providers specializing in oncology research and medical technology. Companies with experience in drug delivery systems and cancer treatment innovation would be well-suited to compete in similar future tenders. By monitoring similar award procedures, businesses can identify emerging research opportunities and collaborations within the healthcare sector, particularly in the development of novel treatment approaches like Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC).

## Notice

This trial aims to determine if a new way of delivering chemotherapy as a spray, directly into the peritoneal cavity, might improve survival in patients with peritoneal metastases, compared to conventional intravenous chemotherapy.

### Lot Information

Lot 1

Bowel, ovarian and stomach cancer often spreads to the lining of the abdominal cavity. This trial aims to determine if a new way of delivering chemotherapy as a spray, directly into the peritoneal cavity, might improve survival in patients with peritoneal metastases, compared to conventional intravenous chemotherapy. Critically, we will also assess the impact of treatment on patient quality of life. Up to 13%, 50% and 14% of patients with bowel, ovarian and stomach cancer respectively, present with peritoneal metastases. When this form of spread occurs, patients are normally told their disease is incurable. As well as a relatively rapid decline, peritoneal metastases can cause a series of unpleasant symptoms due to new tumour growth. Peritoneal metastases are difficult to treat with conventional anticancer drugs and there is an urgent need to develop new treatment strategies. A new strategy showing potential is Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC). PIPAC delivers anti-cancer drugs into the peritoneal cavity as an aerosol during keyhole surgery. PIPAC has been shown to deliver higher doses of chemotherapy directly to tumour sites compared to conventional treatment, with fewer side-effects due to less chemotherapy circulating in the blood. PIPAC has been shown to be both safe and feasible in a series of clinical trials. The question that now remains is whether PIPAC is efficacious or not. PIPAC has excited much interest in patient groups. CAV will disseminate study results through social media, relevant charitable organisations, presentation at academic conferences, peer-reviewed journals as well as through the trial web page hosted at the Centre for Trials Research. Information leaflets, public presentations and media coverage are integral elements of our public engagement plans. The results will strongly influence a future NICE review of PIPAC in the UK.

### Procurement Information

This contract will be awarded to the Cardiff University, who have senior personnel with a large amount of experience in this area of research who are leading on this research project.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Sell2Wales |
| Latest notice | https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=131480 |
| Notice type | OJEU - F15 - Voluntary Ex Ante Transparency Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 11 May 2023 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 11 May 2023 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £1,974,920 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST) |
| Locality | CARDIFF |
| Post town | Cardiff |
| Postcode | CF15 7QZ |
| Country | Wales |
| ITL 1 | TLL Wales |
| ITL 2 | TLL5 South East Wales |
| ITL 3 | TLL51 Central Valleys and Bridgend |
| Local authority | Rhondda Cynon Taf |
| Electoral ward | Taff's Well |
| Westminster constituency | Cardiff North |
| Delivery location | TLL22 Cardiff and Vale of Glamorgan |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | CARDIFF UNIVERSITY |

## CPV Codes

### Divisions

- 79 - Business services: law, marketing, consulting, recruitment, printing and security

### Codes

- 79314000 - Feasibility study

## Release History

- 11 May 2023 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=131480

## Documents

- https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=MAY437035
  PICCOS TRIAL - This trial aims to determine if a new way of delivering chemotherapy as a spray, directly into the peritoneal cavity, might improve survival in patients with peritoneal metastases, compared to conventional intravenous chemotherapy.

## Notice URLs

- http://nwssp.nhs.wales/ourservices/procurement-services/
- http://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=131480
- https://api.sell2wales.gov.wales/v1?lang=cy/Notice?id=ocds-kuma6s-131480

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-kuma6s-131480. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-kuma6s-131480.json.